Prescription status of edaravone and personal importation: Notice of update (English, HTML)

View metadata and access the original English HTML file: Prescription status of edaravone and personal importation: Notice of update.

Format

HTML

Access

file-only

Publisher-reported update

2021-12-29

Organizations and the provinces/territories continue to make progress in the marketing and reimbursement of edaravone (brand name Radicava). Currently, all provinces with the exception of Prince Edward Island (PEI) have updated their drug formularies to include edaravone for public reimbursement. The territories are still in the process of establishing full coverage.

Access original file